In the future, with the enrichment of the datasets with respect to multiple clinicopathological factors including IDH1 mutation status, 1p-19q codeletion status, tumor size, extent of tumor resection, a nomogram model based on multi-omics data would be built to predict the prognosis more efficiently. This evidence concerns the gene IDH1 and neoplasm.